Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma-Reference-Cited by-同舟云学术

Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma

Published:2022-03-09 Issue:5 Volume:19 Page:305-320
ISSN:1759-4812
Container-title:Nature Reviews Urology
language:en
Short-container-title:Nat Rev Urol

Author:

Sager Rebecca A.,Backe Sarah J.,Ahanin Elham,Smith Garrett,Nsouli Imad,Woodford Mark R.,Bratslavsky Gennady^ORCID,Bourboulia Dimitra,Mollapour Mehdi^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

https://www.nature.com/articles/s41585-022-00571-8.pdf

Reference265 articles.

1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin. 70, 7–30 (2020).

2. Hsieh, F. S. et al. Palbociclib induces activation of AMPK and inhibits hepatocellular carcinoma in a CDK4/6-independent manner. Mol. Oncol. 11, 1035–1049 (2017).

3. McDermott, D. F. et al. Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma. J. Clin. Oncol. 23, 133–141 (2005).

4. Motzer, R. J. et al. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet 372, 449–456 (2008).

5. Motzer, R. J. et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N. Engl. J. Med. 356, 115–124 (2007).

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of targeting CDK4/6 in cancer immunotherapy;Holistic Integrative Oncology;2024-06-27

2. CDK4/6 inhibitors dephosphorylate RNF26 to stabilize TSC1 and increase the sensitivity of ccRCC to mTOR inhibitors;British Journal of Cancer;2024-06-18

3. Targeting apoptosis in clear cell renal cell carcinoma;Biomedicine & Pharmacotherapy;2024-06

4. Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma;Nature Reviews Urology;2024-05-02

5. Anti-Cancer Effects of CDK4/6 Inhibitor LEE011 and Chemotherapy Drugs on Lymphocytic Leukemia L1210 Cells;Anticancer Research;2024-02-29